Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pentosan polysulfate sodium

EU orphan designation number: EU/3/14/1359   
Active ingredient: Pentosan polysulfate sodium
Indication: Treatment of mucopolysaccharidosis type I
Sponsor: Plexcera Therapeutics EU Limited
77 Sir John Rogerson's Quay, Dublin 2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2014 Orphan designation EMA/OD/121/14 (2014)8852 of 19/11/2014